1Nakakuki M, Yamasaki F, Shinkawa T, et al. Protective effect of human ulinastatin against gentamicin - induced acute renal failure in rats. Can J Physiol Pharmacol, 1996,74(1): 104-111.
2Ueki M, Yokono S, Taie S, et al. Effects of ulinastatin on postoperative renal function in hepatectomized patients with liver cirrhosis. Masui, 1997,46(2): 251-255.
3Yokono S,Ueki M,Nakano M,et al. Urinary excretion of ulinastatin and NAG after cardiopulmonary bypass. Masui, 1997,46(3): 388-392.
4Kondo D, Imaizumi M, Abe T. Study on extravascular lung water and polymorphonuclear leukocyte elastase during acute phase following radical treatment of lung cancer: effect of ulinastatin on respiratory functions. Kyobu Geka, 1993,46(11): 922～925.
5Hiyama A, Takeda J, Kotake Y, et al. A human urinary protease inhibitor (ulinastatin) inhibits neutrophil extracellular release of elastase during cardiopulmonary bypass. J Cardiothorac Vasc Anesth, 1997,11(5): 580～584.
6Miura M, Sugiura T, Aimi Y, et al. Effect of ulinastatin on PMNL and vascular endothelial injury in patients undergoing open heart surgery with CPB. Masui, 1998,47(1): 29-35.
7Abe H, Kumagai K, Matsuda T, et al. Effect of ulinastatin on the free radical during cardiopulmonary bypass. Masui, 1995,44(7): 1005-1009.
8Sato Y, Ishikawa S, Otaki A, et al. Induction of acute- phase reactive substances during open heart surgery and efficacy of ulinastatin. Inhibiting cytokines and postoperative organ injury.Jpn J Thorac Cardiovasc Surg, 2000,48(7) :428～434.
9Okuhama Y, Shiraishi M, Higa T, et al. protective effects of ulinastatin agaist ischemia- reperfusion injury. J Surg Res,1999,82(1): 34-42.
1[2]Kondo D, Imaizumi M,Abe T. Study on extravascular lung water and polymorphonuclear leukocyte elastase during acute phase following radical treatment of lung cancer:effect of ulinastatin on respiratory functions. Kyobu - Geka, 1993,46 ( 11 ): 922～ 925.
2[3]Mitsuhata H, Enzan K, Hasegawa J, et al. Effect of ulinastatinon change of plasma granulocyte elastase, myeloperoxidase and fibronectin during and after open heart surgery. Masui, 1990, 39 (9): 1164～ 1171.
3[4]Hashimoto K, Nomura K, Nakano M, et al. Pharmacological intervention for renal protection during cardiopulmonary bypass Heart - Vessels, 1993,8 (4): 203～ 210.
4[5]Okuhama Y,Shiraishi M,Higa T,et al . Protective effects of uli nastatin against ischemia -reperfusion injury. J Surg Res, 1999, 82(1) :34～42.
